Showing 1241-1250 of 6036 results for "".
Aberrations in Refractive Cataract Surgery
https://modernod.com/topics/cataractrefractive-surgery/aberrations-in-refractive-cataract-surgery/38896/Remember that good vision is as much about quality as it is about quantity.A Case of MEWDS
https://modernod.com/topics/retina/a-case-of-mewds/38893/This condition typically has a good prognosis, usually requiring only observation.Ocular Surface Squamous Neoplasia in an Avid Sailor With Poor Compliance to Sun Protective Measures
https://modernod.com/mod-issues/novemberdecember-2024-supplement/ocular-surface-squamous-neoplasia-in-an-avid-sailor-with-poor-compliance-to-sun-protective-measures/38886/Ophthalmic Executives Provide Company Updates (Part 2 of 2)
https://modernod.com/podcasts/eyewire-news-the-podcast/ophthalmic-executives-provide-company-updates-part-2-of-2/37058/Leaders of several ophthalmic companies with a focus on the posterior segment provide updates on their pipeline and new products in this special edition of EyewireTV.How to Add Dry Eye Research to Your Clinical Life
https://modernod.com/podcasts/to-the-point/how-to-add-dry-eye-research-to-your-clinical-life/36940/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, are joined by Sathi Maiti, OD, FAAO, who shares her knowledge and experience working on dry eye clinical research. Dr. Maiti offers great advice on what you need to know before seeking out a clinical trial, how to delegate tasks to youOphthalmic Executives Provide Company Updates (Part 1 of 2)
https://modernod.com/podcasts/eyewire-news-the-podcast/ophthalmic-executives-provide-company-updates-part-1-of-2/37057/We hear from executives representing pharma and device manufacturers in the anterior segment who provide updates on their companies’ recently launched products and those in development.Rare, But Not Impossible
https://modernod.com/mod-issues/2024-oct/rare-but-not-impossible/38880/Double Whammy
https://modernod.com/topics/patient-care/double-whammy/38878/Optic neuritis caused by multiple sclerosis is a diagnosis you don’t want to miss.Up Your Keratoconus Game
https://modernod.com/topics/corneaanterior-segment/up-your-keratoconus-game/38871/Advice from an optometrist who sees patients with the disease regularly.Two Partnerships Formed to Advance Glaucoma Treatments
https://modernod.com/podcasts/eyewire-news-the-podcast/two-partnerships-formed-to-advance-glaucoma-treatments/37051/Two collaborations are made to develop and market new glaucoma treatments; Apellis receives feedback from a committee of thee EMA for its geographic atrophy treatment pegcetacoplan; and Topcon receives FDA clearance for OCTA on the company’s Maestro2 fundus camera system.